In this study, we aimed at characterizing FH and FHR1 protein levels in SLE patients and assessing their potential as biomarkers of the disease by comparing them to healthy controls and analyzing their relationship with clinical manifestations of SLE. This evidence concerns the gene FH and systemic lupus erythematosus.